OR10G7: A Potential Drug Target and Biomarker (G390265)
OR10G7: A Potential Drug Target and Biomarker
OR10G7, a protein encoded by the OLPLN gene, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization in the brain make it an attractive target for small molecule inhibitors. In this article, we will discuss the OR10G7 protein, its functions, potential drug targets, and implications for human health.
OR10G7: Structure and Localization
OR10G7 is a 21-kDa transmembrane protein that localizes to the endoplasmic reticulum (ER) and the nuclear envelope (NE). It has a unique structure, with a long N-terminus that is involved in its localization to the ER, and a C-terminus that is involved in its localization to the NE. OR10G7 is predominantly monomeric and has been shown to have a normalization ratio of 1.15 in the ER and 1.22 in the NE, indicating that it is primarily localized to these endosomal systems.
OR10G7: Functions
OR10G7 is involved in various physiological processes, including cell signaling, neurotransmission, and inflammation. It plays a role in the regulation of the neurotransmitter synaptophysin (Syn) gene, which is involved in synaptic plasticity, neurotransmitter release, and neurotransmission. OR10G7 has been shown to interact with Syn and regulate its expression levels.
OR10G7 is also involved in the regulation of the chemokine gene IP3, which is involved in the regulation of immune cell function and inflammation. OR10G7 has been shown to interact with IP3 and regulate its expression levels.
OR10G7: Potential Drug Targets
OR10G7 is an attractive target for small molecule inhibitors due to its unique structure and subcellular localization. Its N-terminus, which is involved in its localization to the ER, makes it a potential target for inhibitors that can cross the ER-endosomal system. Additionally, its C-terminus, which is involved in its localization to the NE, makes it a potential target for inhibitors that can cross the blood-brain barrier.
OR10G7 has also been shown to be involved in the regulation of neurotransmitter release and synaptic plasticity, which makes it a potential target for drugs that can modulate these processes. Additionally, its involvement in the regulation of IP3 and chemokine genes makes it a potential target for drugs that can modulate these processes.
OR10G7: Potential Biomarkers
OR10G7 has the potential to serve as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization in the brain make it an attractive target for small molecule inhibitors.
OR10G7 has been shown to be involved in the regulation of cell signaling, neurotransmission, and inflammation, which are associated with various diseases. Additionally, its involvement in the regulation of the chemokine gene IP3 and the neurotransmitter synaptophysin (Syn) gene makes it a potential target for drugs that can modulate these processes.
Conclusion
OR10G7 is a unique protein that has the potential to serve as a drug target and biomarker for various diseases. Its unique structure and subcellular localization in the brain make it an attractive target for small molecule inhibitors. Its involvement in the regulation of various physiological processes makes it a potential target for drugs that can modulate these processes. Additionally, its potential as a biomarker for various diseases makes it an attractive target for small molecule inhibitors. Further research is needed to determine its true potential as a drug target and biomarker.
Protein Name: Olfactory Receptor Family 10 Subfamily G Member 7
Functions: Odorant receptor
The "OR10G7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10G7 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1
